The latest closing stock price for Y-mAbs Therapeutics as of November 20, 2024 is 10.54.
An investor who bought $1,000 worth of Y-mAbs Therapeutics stock at the IPO in 2018 would have $-561 today, roughly -1 times their original investment - a -12.82% compound annual growth rate over 6 years.
The all-time high Y-mAbs Therapeutics stock closing price was 54.26 on December 17, 2020.
The Y-mAbs Therapeutics 52-week high stock price is 20.90, which is 98.3% above the current share price.
The Y-mAbs Therapeutics 52-week low stock price is 5.29, which is 49.8% below the current share price.
The average Y-mAbs Therapeutics stock price for the last 52 weeks is 12.66.
An investor who bought $1,000 worth of Y-mAbs Therapeutics stock at the IPO in 2018 would have $-561 today, roughly -1 times their original investment - a -12.82% compound annual growth rate over 6 years.
The all-time high Y-mAbs Therapeutics stock closing price was 54.26 on December 17, 2020.
The Y-mAbs Therapeutics 52-week high stock price is 20.90, which is 98.3% above the current share price.
The Y-mAbs Therapeutics 52-week low stock price is 5.29, which is 49.8% below the current share price.
The average Y-mAbs Therapeutics stock price for the last 52 weeks is 12.66.